BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

1.890

-0.020 (-1.05%)

At close: Jul 21, 2025, 4:00 PM

1.950

+0.060 (3.17%)

After-hours: Jul 21, 2025, 4:52 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Neuroscience and Immuno-oncology Drugs	1.38M	Log In
Neuroscience and Immuno-oncology Drugs Growth	268.00%	Log In

Revenue by Geography

Fiscal year is January - December.